In order to ensure sufficient predictability for health technology developers as to their opportunity to engage in joint scientific consultations on medicinal products with the Coordination Group, it is necessary to specify the deadline for the Coordination Group to set the dates of request periods for joint scientific consultation on medicinal products for the subsequent year, as well as the minimum number of such request periods per year. Under Article 6(2), point (b), of Regulation (EU) 2021/2282, the Coordination Group is to set out in its annual work programme the planned number of joint scientific consultations. To allow the health technology developers sufficient time to plan and prepare for joint scientific consultations on medicinal products, the Coordination Group should set the request periods for those consultations at the latest by the day on which it adopts its annual work programme, that is, by 30 November each year.
Recital 3, Regulation (EU) 2024/3169
In forcesince 18 Dec 2024